IACOVELLI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 1.420
EU - Europa 1.271
AS - Asia 883
SA - Sud America 99
Continente sconosciuto - Info sul continente non disponibili 47
AF - Africa 36
Totale 3.756
Nazione #
US - Stati Uniti d'America 1.355
RU - Federazione Russa 505
SG - Singapore 303
CN - Cina 299
GB - Regno Unito 267
IT - Italia 149
SE - Svezia 80
VN - Vietnam 78
BR - Brasile 72
HK - Hong Kong 68
IE - Irlanda 66
DE - Germania 65
FR - Francia 51
CA - Canada 31
KR - Corea 28
BD - Bangladesh 19
MX - Messico 19
FI - Finlandia 18
IN - India 17
AR - Argentina 11
NG - Nigeria 11
NL - Olanda 11
ID - Indonesia 10
JP - Giappone 10
PL - Polonia 9
UA - Ucraina 9
AT - Austria 6
MA - Marocco 6
TR - Turchia 6
UZ - Uzbekistan 6
ZA - Sudafrica 6
BE - Belgio 5
EC - Ecuador 5
ES - Italia 5
AZ - Azerbaigian 4
CW - ???statistics.table.value.countryCode.CW??? 4
IQ - Iraq 4
PH - Filippine 4
PK - Pakistan 4
AL - Albania 3
CH - Svizzera 3
CO - Colombia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
GT - Guatemala 3
PY - Paraguay 3
RS - Serbia 3
SA - Arabia Saudita 3
SC - Seychelles 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
CR - Costa Rica 2
GR - Grecia 2
HR - Croazia 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
SV - El Salvador 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
YE - Yemen 1
Totale 3.713
Città #
Southend 241
Ashburn 226
Moscow 171
Chandler 153
Singapore 149
San Jose 130
Dallas 77
Hong Kong 67
Dublin 66
Beijing 63
The Dalles 44
Ann Arbor 39
Verona 39
Council Bluffs 37
Los Angeles 35
New York 31
Houston 30
Jacksonville 29
Jinan 24
Santa Clara 24
Nanjing 22
Lawrence 20
Princeton 20
Wilmington 19
Montreal 16
São Paulo 16
Ho Chi Minh City 15
Shenyang 14
Helsinki 13
Hebei 12
Tianjin 12
Abuja 11
Dong Ket 11
Munich 11
Rome 11
Hanoi 10
Kent 10
Redwood City 10
Buffalo 9
Columbus 9
Dearborn 9
Redondo Beach 9
Tokyo 9
Guangzhou 8
Haikou 8
Mexico City 8
Seoul 8
Taizhou 8
Las Vegas 7
Denver 6
Haiphong 6
Jakarta 6
Tashkent 6
Vienna 6
Warsaw 6
Brussels 5
Johannesburg 5
Lanzhou 5
Milan 5
Ningbo 5
Seattle 5
Sindelfingen 5
Amsterdam 4
Baku 4
Boston 4
Changsha 4
Chennai 4
Nanchang 4
Stockholm 4
Toronto 4
Willemstad 4
Woodbridge 4
Belgrade 3
Belo Horizonte 3
Brooklyn 3
Buenos Aires 3
Cairo 3
Campinas 3
Chicago 3
Detroit 3
Falkenstein 3
Frankfurt am Main 3
Fuzhou 3
Hangzhou 3
Istanbul 3
Jiaxing 3
Louisville 3
Nave 3
New Delhi 3
Orem 3
Padua 3
Paris 3
Phoenix 3
Prague 3
Querétaro 3
Renton 3
Santiago 3
Taiyuan 3
Tirana 3
Zhengzhou 3
Totale 2.215
Nome #
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 263
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 228
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 221
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer 216
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 214
Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies 212
The development of PARP as a successful target for cancer therapy 198
De novo metastatic castration sensitive prostate cancer: State of art and future perspectives 198
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach 198
Renal cell carcinoma in one year: Going inside the news of 2017 - A report of the main advances in RCC cancer research 197
Immunotherapy versus standard of care in metastatic renal cell carcinoma. A systematic review and meta-analysis 187
Positive Association between Preoperative Total Testosterone Levels and Risk of Positive Surgical Margins by Prostate Cancer: Results in 476 Consecutive Patients Treated Only by Radical Prostatectomy 177
Metabolic phenotype of bladder cancer 176
Inside the 2015 ASCO Genitourinary Cancers Symposium 167
Prostate cancer heterogeneity: Discovering novel molecular targets for therapy 160
Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 2 - prostate and bladder cancer 159
Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 1 - kidney cancer 153
Predictive role of changes in the tumor burden and International Metastatic Renal Cell Carcinoma Database Consortium class during active surveillance for metastatic renal cell carcinoma 150
Re: Ian D. Davis, Wanling Xie, Carmel Pezaro, et al. Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category. Eur Urol 2017;71:970-8: The Change in Baseline IMDC Prognostic Category: From the Past, Implications for the Future 147
Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer 135
Totale 3.756
Categoria #
all - tutte 12.727
article - articoli 12.727
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.454


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202281 0 0 0 0 16 5 1 10 3 5 2 39
2022/2023405 22 49 34 58 33 112 4 34 49 3 5 2
2023/2024184 5 18 7 16 42 22 3 18 0 9 39 5
2024/2025449 18 21 23 107 19 14 9 9 95 23 37 74
2025/20261.633 108 61 95 292 426 100 138 69 158 119 31 36
2026/2027223 6 26 46 119 26 0 0 0 0 0 0 0
Totale 3.756